Abstract
Over the past two decades, Biomedical Engineering (BME) has emerged as a major discipline bridging societal healthcare needs with novel technology development. We are now at the nexus of creating "avatars"—extensions of digital twins—of human physiology to serve as paradigms for interrogation and intervention. This paper, a result of an interdisciplinary workshop sponsored by the IEEE EMBS, Johns Hopkins University, and UC San Diego, identifies five grand challenges: 1) AccuMedicine through avatars; 2) smart and responsive devices for human augmentation; 3) exocortical technologies for brain function; 4) harnessing the immune system; and 5) engineering genomes and cells.
Introduction: From Reactive to Proactive Healthcare
Despite the explosion of biological data from genomics and advanced imaging, modern healthcare remains largely reactive and generalized. While we can monitor human health at unprecedented scales, the field lacks integrated models to translate this "multiscale myriad" of data into precise, actionable outcomes for individual patients.
The authors propose a unified vision for BME, arguing that the discipline must move beyond tool-building to lead the creation of a new "engineering basis of human physiology." This shift toward "AccuMedicine" requires solving massive technical hurdles in data integration, real-time sensing, and therapeutic delivery.
The Five Grand Challenges
1. Precision Medicine and Human Avatars
The concept of a human "avatar" goes beyond a standard digital twin. It includes both in-silico models and physical, ex vivo surrogates, such as patient-specific organ-on-a-chip systems. These avatars allow clinicians to test interventions on a physical manifestation of the patient before applying them to the body, integrating genomic, transcriptomic, and lifestyle data for real-time feedback.
2. The Smart Human: Augmenting Function
This challenge focuses on developing permanent, responsive systems—such as artificial lungs or prosthetic limbs—that sense their environment and adapt in real-time. The goal is to ensure homeostasis and augment human function through smart, autonomous devices.
3. The ExoBrain: Engineering the Mind
The "ExoBrain" represents an external processing layer interfacing with the biological brain. This involves mapping the brain across ten orders of magnitude (from synapses to whole-brain imaging) and developing non-invasive neuroaugmentation technologies to treat neurodegeneration and mirror brain function externally.
4. Immuno-Engineering: The Immune Toolbox
Rather than simply "boosting" the immune system, the goal is to create a "toolbox" to quantify and program immune cell phenotypes with mechanical precision. This includes engineering next-generation vaccines and therapies that can establish immunological tolerance for autoimmune diseases.
5. Engineering Life: The Genome as Software
DNA is framed as "hardware" and epigenetic regulation as the "operating system." Mastering "Engineering Life" requires moving from reading the code to controlling the OS. A primary bottleneck is the "delivery challenge"—creating safe, tissue-targeted systems that can edit the genome in vivo.
Strategic Roadmap and Enabling Technologies
The roadmap was developed by synthesizing expert perspectives on societal needs, technical hurdles, and enabling technologies. Key enablers include:
- Multimodal Sensing: Developing sensors for dynamic feedback of the "digital human."
- Data Science & AI: Bridging the gap between nanoscale molecular data and whole-body outcomes.
- Advanced Materials: Utilizing cell manufacturing and material science for tissue fabrication and microphysiological platforms.
Limitations and Future Outlook
The transition to this engineering-driven future faces several hurdles:
- The Delivery Bottleneck: Getting therapeutic payloads to specific cells without toxicity remains a major challenge for gene and cell therapies.
- Model Poverty: The field is currently "data rich but model poor." Computational challenges in bridging scales are significant.
- Education and Ethics: BME education must evolve to include ethics, data science, and clinical medicine as core pillars to avoid working in silos.
- Regulatory Evolution: Moving from animal models to human surrogates (like organ-on-a-chip) for drug approval requires a difficult but necessary regulatory transition.
By addressing these challenges, the 21st century will see engineering and medicine become indistinguishable, ushering in an era of proactive, personalized health maintenance.
Summary updated